Balance Sheet - Kymera Therapeutics, Inc. (KYMR)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.85 | 0.49 | 0.37 | 0.41 | 0.44 | 0.30 | 0.09 | 0.04 |
| Accounts receivable, net | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 0.00 | -0.01 | -0.01 | -0.16 | ||||
| Other current assets | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Total current assets | 0.87 | 0.51 | 0.41 | 0.42 | 0.45 | 0.30 | 0.09 | 0.04 |
| Total non-current assets | 0.87 | 0.47 | 0.17 | 0.18 | 0.15 | 0.18 | 0.02 | 0.00 |
| Total assets | 1.74 | 0.98 | 0.58 | 0.60 | 0.61 | 0.49 | 0.12 | 0.04 |
| Total current liabilities | 0.08 | 0.07 | 0.09 | 0.07 | 0.09 | 0.11 | 0.03 | 0.00 |
| Total non-current liabilities | 0.08 | 0.07 | 0.10 | 0.04 | 0.05 | 0.09 | 0.16 | 0.07 |
| Total liabilities | 0.16 | 0.14 | 0.18 | 0.11 | 0.15 | 0.20 | 0.19 | 0.08 |
| Total stockholders' equity | 1.58 | 0.84 | 0.39 | 0.49 | 0.46 | 0.28 | -0.07 | -0.03 |
| Common shares outstanding | 84 | 75 | 58 | 54 | 48 | 45 | 45 | 45 |
Show Quarterly Balance Sheet
Balance Sheet - Kymera Therapeutics, Inc. (KYMR)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.65 | 0.85 | 0.51 | 0.67 | 0.46 | 0.49 | 0.55 | 0.51 | 0.52 | 0.37 | 0.36 | 0.37 | 0.40 | 0.41 | 0.48 | 0.39 | 0.42 | 0.44 | 0.54 | 0.36 | 0.33 | 0.30 | 0.29 | 0.16 | 0.00 | 0.09 | 0.00 |
| Accounts receivable, net | 0.04 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | -0.16 | |||||||||||||||||||
| Other current assets | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total current assets | 0.68 | 0.87 | 0.53 | 0.73 | 0.50 | 0.51 | 0.57 | 0.53 | 0.54 | 0.41 | 0.38 | 0.39 | 0.41 | 0.42 | 0.49 | 0.40 | 0.43 | 0.45 | 0.54 | 0.36 | 0.34 | 0.30 | 0.30 | 0.16 | 0.16 | 0.09 | 0.09 |
| Total non-current assets | 0.99 | 0.87 | 0.57 | 0.40 | 0.42 | 0.47 | 0.47 | 0.30 | 0.33 | 0.17 | 0.18 | 0.20 | 0.20 | 0.18 | 0.14 | 0.12 | 0.13 | 0.15 | 0.10 | 0.07 | 0.12 | 0.18 | 0.21 | 0.02 | 0.02 | ||
| Total assets | 1.67 | 1.74 | 1.10 | 1.13 | 0.92 | 0.98 | 1.03 | 0.83 | 0.87 | 0.58 | 0.55 | 0.58 | 0.61 | 0.60 | 0.64 | 0.52 | 0.56 | 0.61 | 0.64 | 0.43 | 0.46 | 0.49 | 0.51 | 0.18 | 0.12 | ||
| Total current liabilities | 0.06 | 0.08 | 0.07 | 0.09 | 0.06 | 0.07 | 0.07 | 0.06 | 0.06 | 0.09 | 0.06 | 0.05 | 0.06 | 0.07 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.11 | 0.11 | 0.11 | 0.11 | 0.04 | 0.04 | 0.03 | 0.03 |
| Total non-current liabilities | 0.07 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.08 | 0.08 | 0.10 | 0.10 | 0.09 | 0.09 | 0.09 | 0.04 | 0.03 | 0.04 | 0.05 | 0.05 | 0.06 | 0.07 | 0.08 | 0.09 | 0.11 | 0.03 | 0.16 | ||
| Total liabilities | 0.13 | 0.16 | 0.16 | 0.16 | 0.13 | 0.14 | 0.14 | 0.14 | 0.16 | 0.18 | 0.16 | 0.15 | 0.15 | 0.11 | 0.13 | 0.13 | 0.13 | 0.15 | 0.16 | 0.18 | 0.19 | 0.20 | 0.21 | 0.08 | 0.19 | ||
| Total stockholders' equity | 1.54 | 1.58 | 0.95 | 0.97 | 0.79 | 0.84 | 0.89 | 0.68 | 0.71 | 0.39 | 0.40 | 0.44 | 0.46 | 0.49 | 0.51 | 0.40 | 0.43 | 0.46 | 0.48 | 0.26 | 0.28 | 0.28 | 0.29 | 0.10 | -0.07 | ||
| Common shares outstanding | 98 | 84 | 87 | 80 | 80 | 80 | 76 | 73 | 71 | 59 | 58 | 58 | 58 | 58 | 55 | 52 | 52 | 51 | 51 | 45 | 45 | 44 | 44 | 43 | 45 | 45 | 45 |